搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 7 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Japan's moon lander wasn't built to survive a weekslong lunar night. It's still ...
Bastillepost· 5 日前Ouro, a global fintech company founded in 1999 by former University of Texas (UT) students and ...
China's robotic spacecraft to be sent to the moon
China Daily· 2 日前A Long March 5 carrier rocket, with the 8.2-metric-ton Chang'e 6 probe on top of it, was vertically moved ...